These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 26018685)
21. Therapeutic strategy of papillary microcarcinoma of the thyroid gland: a nuclear medicine perspective. Riemann B; Schober O Minerva Endocrinol; 2009 Mar; 34(1):81-7. PubMed ID: 19209130 [TBL] [Abstract][Full Text] [Related]
22. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma. Sohn MH; Kim MW; Lim ST; Lee NR; Song EK; Yim CY Clin Nucl Med; 2005 Apr; 30(4):269-70. PubMed ID: 15764888 [TBL] [Abstract][Full Text] [Related]
23. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315 [TBL] [Abstract][Full Text] [Related]
24. Metastatic differentiated carcinoma of the thyroid and radioiodine. Andrews JT; McGennisken MR Australas Radiol; 1987 Feb; 31(1):41-6. PubMed ID: 3619809 [No Abstract] [Full Text] [Related]
25. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Fatourechi V; Hay ID; Mullan BP; Wiseman GA; Eghbali-Fatourechi GZ; Thorson LM; Gorman CA Thyroid; 2000 Jul; 10(7):573-7. PubMed ID: 10958309 [TBL] [Abstract][Full Text] [Related]
26. Lung adenocarcinoma and pulmonary metastases coexist in a patient with papillary thyroid carcinoma: A case report. Cheng C; Zhou J; Shao X Medicine (Baltimore); 2017 Dec; 96(49):e9078. PubMed ID: 29245323 [TBL] [Abstract][Full Text] [Related]
27. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan. Kaya M; Cermik TF Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510 [TBL] [Abstract][Full Text] [Related]
28. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131. Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934 [TBL] [Abstract][Full Text] [Related]
29. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid. Leboeuf R; Bénard F; Langlois MF Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803 [TBL] [Abstract][Full Text] [Related]
30. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake. Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452 [TBL] [Abstract][Full Text] [Related]
31. Aggressive behavior of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass. Braga M; Graf H; Ogata A; Batista J; Hakim NC J Endocrinol Invest; 2002 Mar; 25(3):250-3. PubMed ID: 11936468 [TBL] [Abstract][Full Text] [Related]
32. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma. Silberstein EB J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976 [TBL] [Abstract][Full Text] [Related]
33. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515 [TBL] [Abstract][Full Text] [Related]
34. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341 [TBL] [Abstract][Full Text] [Related]
35. [Thyroid papillary microcarcinoma. Salah Azaiz Institute experience]. Oueslati Z; Aloui M; Gritli S; Touati S; el-May A; Gamoudi A; Ben-Slimene F; Ladgham A Rev Laryngol Otol Rhinol (Bord); 2002; 123(1):39-42. PubMed ID: 12200999 [TBL] [Abstract][Full Text] [Related]
36. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma. Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516 [TBL] [Abstract][Full Text] [Related]
37. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report]. Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219 [TBL] [Abstract][Full Text] [Related]
38. [Dynamics of the x-ray picture of bone metastases of thyroid cancer as affected by radiotherapy]. Kiseleva ES; Zvekotkina LS; Babushkin VV Med Radiol (Mosk); 1989 Mar; 34(3):6-10. PubMed ID: 2927278 [TBL] [Abstract][Full Text] [Related]
39. Incidental thyroid 99mTc-MDP uptake in a patient affected by differentiated thyroid cancer. Albano D; Magri GC; Treglia G; Bertagna F Nucl Med Rev Cent East Eur; 2016; 19(B):8-10. PubMed ID: 27813621 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature. Zhang X; Liu DS; Luan ZS; Zhang F; Liu XH; Zhou W; Zhong SF; Lai H Clin Transl Oncol; 2018 Jul; 20(7):928-935. PubMed ID: 29119458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]